Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Bevacizumab Followed by Steroid in Radiation-induced Brain Injury
NCT04553510Phase 2Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2020
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, prednisone in Radiation-Induced Brain Injury (RIBI), sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
bevacizumabprednisone
03
Conditions
Radiation-Induced Brain Injury (RIBI)
Beyond the preview
Go deeper on NCT04553510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04553510.